125.05
0.63%
0.78
アフターアワーズ:
125.14
0.09
+0.07%
前日終値:
$124.27
開ける:
$124.63
24時間の取引高:
375.71K
Relative Volume:
0.65
時価総額:
$7.57B
収益:
$3.99B
当期純損益:
$463.16M
株価収益率:
17.61
EPS:
7.1
ネットキャッシュフロー:
$1.10B
1週間 パフォーマンス:
+2.10%
1か月 パフォーマンス:
+1.69%
6か月 パフォーマンス:
+11.38%
1年 パフォーマンス:
-0.41%
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
名前
Jazz Pharmaceuticals Plc
セクター
電話
353-1-634-7800
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
JAZZ を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
125.05 | 7.57B | 3.99B | 463.16M | 1.10B | 7.10 |
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2024-06-05 | 開始されました | Goldman | Buy |
2024-01-03 | 開始されました | Robert W. Baird | Outperform |
2023-11-27 | ダウングレード | UBS | Buy → Neutral |
2023-09-29 | 開始されました | Raymond James | Mkt Perform |
2023-06-12 | 再開されました | Wells Fargo | Equal Weight |
2022-12-09 | アップグレード | Goldman | Neutral → Buy |
2022-06-14 | 開始されました | UBS | Buy |
2022-04-06 | ダウングレード | Goldman | Buy → Neutral |
2021-11-19 | 再開されました | Goldman | Buy |
2021-10-07 | 再開されました | Jefferies | Buy |
2021-10-05 | 開始されました | Citigroup | Buy |
2021-09-23 | 開始されました | Needham | Buy |
2021-05-19 | 再開されました | JP Morgan | Overweight |
2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
2021-02-05 | 繰り返されました | H.C. Wainwright | Buy |
2021-02-03 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-01-29 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2020-12-16 | 開始されました | UBS | Buy |
2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
2020-10-09 | 繰り返されました | H.C. Wainwright | Buy |
2020-09-14 | ダウングレード | Goldman | Neutral → Sell |
2020-09-14 | 再開されました | JP Morgan | Overweight |
2020-08-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-07-28 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2020-07-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-04-06 | 開始されました | Jefferies | Buy |
2020-03-12 | アップグレード | Bernstein | Mkt Perform → Outperform |
2020-01-08 | 開始されました | Goldman | Neutral |
2019-08-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2019-06-11 | 開始されました | Barclays | Overweight |
2019-03-20 | 開始されました | SunTrust | Buy |
2018-12-14 | 開始されました | Wolfe Research | Peer Perform |
2018-11-08 | 繰り返されました | B. Riley FBR | Buy |
2018-08-08 | 繰り返されました | Stifel | Buy |
2018-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2018-03-23 | 繰り返されました | H.C. Wainwright | Neutral |
2018-03-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース
Leerink Partnrs Issues Optimistic Forecast for JAZZ Earnings - MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) investors are sitting on a loss of 14% if they invested five years ago - Simply Wall St
KBC Group NV Has $29.10 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Pacer Advisors Inc. Purchases 115,102 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Perpetual Ltd Sells 81,043 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Lmcg Investments LLC Takes $5.60 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
MassMutual Private Wealth & Trust FSB Has $2.19 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
2,442 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Aaron Wealth Advisors LLC - MarketBeat
Arkadios Wealth Advisors Invests $716,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Short Interest Update - MarketBeat
Kera Capital Partners Inc. Buys New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Wedge Capital Management L L P NC Sells 48,679 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Empirical Asset Management LLC Invests $5.36 Million in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Hennion & Walsh Asset Management Inc. Has $4.42 Million Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Burney Co. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline - MSN
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
JAZZ (Jazz Pharmaceuticals) Growth Rank : 7 (As of Jan. 15, 2025) - GuruFocus.com
Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
Serina Therapeutics Appoints Former Jazz Pharmaceuticals Finance Executive Karen Wilson to Board - StockTitan
Acute Lymphocytic Leukemia Pipeline Analysis 2024: FDA - openPR
With EPS Growth And More, Jazz Pharmaceuticals (NASDAQ:JAZZ) Makes An Interesting Case - Simply Wall St
Jazz Pharmaceuticals CEO sells shares worth $185,145 By Investing.com - Investing.com Nigeria
Insider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Sells 1,500 Shares of Stock - MarketBeat
Jazz Pharmaceuticals CEO sells shares worth $185,145 - Investing.com India
Centre Asset Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $177.00 Consensus Target Price from Analysts - MarketBeat
JPMorgan Chase & Co. Lowers Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Principal Financial Group Inc. Sells 66,821 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Sentiment Still Eluding Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Simply Wall St
Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 (NASDAQ:JAZZ) - Seeking Alpha
Drug Resistant Epilepsy Market Growth, Trends & Key Players - openPR
Barclays PLC Has $4.37 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Sanctuary Advisors LLC Acquires 9,804 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Akari Therapeutics Names Interim CEO Patel as Permanent Chief, Adds Jazz Pharma Veteran to Board - StockTitan
Jazz Pharmaceuticals CEO to retire by end 2025, search begins - Investing.com Australia
Public Employees Retirement System of Ohio Makes New $2.49 Million Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals CEO to Present Strategic Vision at JP Morgan Healthcare Conference 2025 - StockTitan
Big Peninsula drugmaker on the hunt for new CEO - The Business Journals
Jazz Pharmaceuticals CEO to Retire, Succession Search Underway - Sleep Review
Graft-Versus-Host Disease Market on Track for Major Expansion - openPR
Jazz Pharmaceuticals Announces CEO Succession Plan - PharmiWeb.com
Jazz Pharmaceuticals CEO to retire - MSN
Bruce Cozadd to retire as Jazz’s CEO - BioCentury
Bruce Cozadd to Retire as Chief Executive Officer of Jazz Pharmaceuticals plc Upon Appointment of Successor by the End of 2025 - Marketscreener.com
Jazz Pharmaceuticals CEO to retire by end of 2025 - Investing.com South Africa
Jazz to search for new chief as CEO plans retirement - BioPharma Dive
Jazz Pharmaceuticals Plc (JAZZ) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):